Cargando…
Screening for Hepatocellular Carcinoma in Chronic Hepatitis B: An Update
(1) Background: Hepatocellular carcinoma (HCC) is an important cause of mortality in individuals with chronic hepatitis B infection, with screening of high-risk groups recommended in all major international guidelines. Our understanding of the risk factors involved has improved over time, encouragin...
Autores principales: | Lok, James, Agarwal, Kosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8309969/ https://www.ncbi.nlm.nih.gov/pubmed/34372539 http://dx.doi.org/10.3390/v13071333 |
Ejemplares similares
-
Tenofovir alafenamide in the treatment of chronic hepatitis B virus
infection: rationale and clinical trial evidence
por: Byrne, Ruth, et al.
Publicado: (2018) -
Health inequalities in the management of chronic hepatitis B virus infection in patients from sub-Saharan Africa in high-income countries
por: Mitchell, Tim, et al.
Publicado: (2022) -
Screening for Hepatocellular Carcinoma in Patients with Hepatitis B
por: Sachar, Yashasavi, et al.
Publicado: (2021) -
Reactivation of hepatitis B virus infection in patients with hematologic disorders
por: Wang, Bo, et al.
Publicado: (2019) -
Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus Infection
por: Hsu, Axel, et al.
Publicado: (2011)